Litcius/Paper detail

Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1

Xueni Niu, Yinuo Shi, Qiao Li, Hong Chen, Xiaoyu Fan, Yang Yu, Chongning Lv, Jincai Lu

2023Phytomedicine23 citationsDOI

Topics & Concepts

CisplatinGinsengPharmacologyGinsenosideIn vivoA549 cellChemistryMTT assayApoptosisCancer researchMedicineBiologyBiochemistryChemotherapyInternal medicinePathologyBiotechnologyAlternative medicineHedgehog Signaling Pathway StudiesDrug Transport and Resistance MechanismsNatural Compounds in Disease Treatment
Ginsenoside Rb1 for overcoming cisplatin-insensitivity of A549/DDP cells in vitro and vivo through the dual-inhibition on two efflux pumps of ABCB1 and PTCH1 | Litcius